Intensification of Doxorubicin-Related Oxidative Stress in the Heart by Hypothyroidism Is Not Related to the Expression of Cytochrome P450 NADPH-Reductase and Inducible Nitric Oxide Synthase, As Well As Activity of Xanthine Oxidase

Malonyldialdehyd and 4-hydroxynonenal concentration (nmol/g of cardiac sample; <svg height="12.05" id="M17" style="vertical-align:-1.09097pt" version="1.1" viewbox="0 0 54 12.05" width="54" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,12.05)">
<g transform="translate(72,-62.36)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑋</tspan>
<tspan style="font-size: 12.50px; " x="12.653036" y="0">±</tspan>
<tspan style="font-size: 12.50px; " x="23.993258" y="0">S</tspan>
<tspan style="font-size: 12.50px; " x="30.944925" y="0">.</tspan>
<tspan style="font-size: 12.50px; " x="34.070675" y="0">D</tspan>
</text>
</g>
</g>
</svg>.) in rat cardiac homogenates 4, 48, and 96 h after doxorubicin administration.

Oxidative Medicine and Cellular Longevity

tab2

Table 2

Table 2: Intensification of Doxorubicin-Related Oxidative Stress in the Heart by Hypothyroidism Is Not Related to the Expression of Cytochrome P450 NADPH-Reductase and Inducible Nitric Oxide Synthase, As Well As Activity of Xanthine Oxidase 

Table 2 | Intensification of Doxorubicin-Related Oxidative Stress in the Heart by Hypothyroidism Is Not Related to the Expression of Cytochrome P450 NADPH-Reductase and Inducible Nitric Oxide Synthase, As Well As Activity of Xanthine Oxidase 